Technical Analysis for HELX - Franklin Genomic Advancements ETF
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Strong | Down | Down | Down |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Slingshot Bearish | Bearish Swing Setup | 0.00% | |
| Volume Surge | Other | 0.00% | |
| Narrow Range Bar | Range Contraction | 0.00% | |
| Gapped Up | Strength | 0.00% | |
| Oversold Stochastic | Weakness | 0.00% | |
| New Downtrend | Bearish | 0.95% | |
| Cup with Handle | Other | 0.95% | |
| Volume Surge | Other | 0.95% | |
| Narrow Range Bar | Range Contraction | 0.95% | |
| Below Lower BB | Weakness | 0.95% |
| Alert | Time |
|---|---|
| 2x Volume Pace | about 22 hours ago |
| 1.5x Volume Pace | about 22 hours ago |
| 3x Volume Pace | about 22 hours ago |
| 60 Minute Opening Range Breakdown | about 22 hours ago |
| Gapped Up (Full) | about 23 hours ago |
Get this analysis on your stocks daily!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
Seeks capital appreciation by investing in innovative companies related to genomic-based technologies designed to enhance the quality of life.
Provides access to companies benefitting from or facilitating the use of new research including DNA sequencing, gene editing and personalized medicine
Uses bottom-up fundamental research conducted by dedicated, industry-specific analysts to identify disruptive business models at the right stage for investment
Actively managed by a seasoned portfolio management team that is based in Silicon Valley and has a long history of investing in the craft of innovation
Keywords: Exchange Traded Fund ETF Biotechnology Life Sciences Biology Emerging Technologies Molecular Biology Genetics Portfolio Management Quality Of Life Personalized Medicine DNA DNA Sequencing
Classification
Keywords: Exchange Traded Fund ETF Biotechnology Life Sciences Biology Emerging Technologies Molecular Biology Genetics Portfolio Management Quality Of Life Personalized Medicine DNA DNA Sequencing
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Date | Title |
|---|---|
| Oct 22 | Why Is Medpace Stock Diving On Tuesday? |
| Indicator | Value |
|---|---|
| 52 Week High | 33.9761 |
| 52 Week Low | 25.78 |
| Average Volume | 1,729 |
| 200-Day Moving Average | 31.82 |
| 50-Day Moving Average | 32.20 |
| 20-Day Moving Average | 31.46 |
| 10-Day Moving Average | 30.94 |
| Average True Range | 0.33 |
| RSI (14) | 35.06 |
| ADX | 26.33 |
| +DI | 21.47 |
| -DI | 49.45 |
| Chandelier Exit (Long, 3 ATRs) | 31.45 |
| Chandelier Exit (Short, 3 ATRs) | 31.18 |
| Upper Bollinger Bands | 32.79 |
| Lower Bollinger Band | 30.14 |
| Percent B (%b) | 0.14 |
| BandWidth | 8.40 |
| MACD Line | -0.47 |
| MACD Signal Line | -0.36 |
| MACD Histogram | -0.1096 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 30.68 | ||||
| Resistance 3 (R3) | 30.68 | 30.62 | 30.65 | ||
| Resistance 2 (R2) | 30.62 | 30.58 | 30.62 | 30.64 | |
| Resistance 1 (R1) | 30.56 | 30.55 | 30.54 | 30.56 | 30.63 |
| Pivot Point | 30.51 | 30.51 | 30.49 | 30.51 | 30.51 |
| Support 1 (S1) | 30.45 | 30.46 | 30.42 | 30.45 | 30.39 |
| Support 2 (S2) | 30.39 | 30.44 | 30.39 | 30.38 | |
| Support 3 (S3) | 30.34 | 30.39 | 30.37 | ||
| Support 4 (S4) | 30.34 |
